Clinical Trial Update: Rostock International Parkinson's Disease Study (ROPAD)

View source ↗

Summary

This clinical trial update notes that the Rostock International Parkinson's Disease Study (ROPAD), sponsored by CENTOGENE GmbH Rostock, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: CENTOGENE GmbH Rostock | Conditions: Parkinson´s Disease | Status: COMPLETED